| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-DRA |
|
0.7 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
HNRPA2B1 |
IPI00414696 |
0.7 |
Evidence |
|
| SNRPA1 |
SNRPA1: U2 small nuclear ribonucleoprotein A' |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
0.7 |
Evidence |
|
| PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
NCOA3 |
IPI00220082 |
0.7 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
0.7 |
Evidence |
|
| VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
EEF1D |
EEF1D: EEF1D protein |
0.698 |
Evidence |
|
| MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
0.698 |
Evidence |
|
| EEF1A2 |
EEF1A2, EEF1AL, STN: Elongation factor 1-alpha 2 |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.698 |
Evidence |
|
| HNRPK |
IPI00216746 |
XRN2 |
XRN2: 5'-3' exoribonuclease 2 |
0.698 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
RTN4 |
RTN4, KIAA0886, My043, NOGO, SP1507: Reticulon-4 |
0.698 |
Evidence |
|
| RAD17 |
RAD17, R24L: Cell cycle checkpoint protein RAD17 |
HSP90AA1 |
Hsp89-alpha-delta-N |
0.698 |
Evidence |
|
| MAP3K7 |
MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 |
RPL7 |
RPL7: 60S ribosomal protein L7 |
0.698 |
Evidence |
|
| HIST1H2BO |
HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O |
UBE2B |
UBE2B, RAD6B: Ubiquitin-conjugating enzyme E2 B |
0.698 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
0.698 |
Evidence |
|
| TOB1 |
TOB1, TOB, TROB1: Protein Tob1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
0.698 |
Evidence |
|
| FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
GNB1 |
GNB1: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
0.698 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
EIF4EBP1 |
EIF4EBP1: Eukaryotic translation initiation factor 4E-binding protein 1 |
0.698 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
0.698 |
Evidence |
|
| POLB |
POLB: DNA polymerase beta |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
0.698 |
Evidence |
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
ARRB2 |
IPI00027355 |
0.698 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
0.698 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
0.698 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MAP4K5 |
MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 |
0.698 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
0.698 |
Evidence |
|
| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.698 |
Evidence |
|